Metabolic Disease Services Platform
Metabolic diseases are considered to arise from multiple factors, including genetics, diet, age, and environmental factors, and often affect various organs throughout the body. No single cause is solely responsible for these disorders.
To support research in this area, WuXi AppTec offers a comprehensive platform of in vitro and in vivo services. Our capabilities include a well-established panel of validated and clinically relevant animal models, as well as advanced technologies for studying obesity, diabetes, hyperlipidemia, and rare metabolic diseases.
• Clinically relevant models that mirror clinical profiles for effective drug screening and assessment.
• Comprehensive system for metabolic disease treatment evaluation.
• Extensive metabolic research experience and robust drug evaluation system.
Learn more about our metabolic disease service platform by clicking HERE

Metabolic Disease Platform
Related Content
Metabolic dysfunction-associated alcohol-related liver disease (MetALD) presents unique challenges for preclinical drug development, requiring models that capture the combined effects...
VIEW RESOURCEMetabolic dysfunction-associated steatohepatitis (MASH) remains a significant global health challenge, driven by a complex interplay of lipid dysregulation, inflammation, and...
VIEW RESOURCE
